1-3, 1-6 Beta Glucan

Numerous research papers have been produced on 1-3, 1-6 beta glucans generally and WGP 3-6 specifically, from influential institutions that include Harvard, University of California, the U.S. Food and Drug Administration, the US Armed Forces Radiology Research Institute, and University of Washington.

They have demonstrated the immune activating properties of beta glucans via the stimulation or priming of macrophage and neutrophil cells

Experiments in 2000-2001 at the University of Nevada School of Medicine confirmed prior research as to the oral effectiveness of beta glucan in activating immunity. Macrophages in both studies significantly increased their immune response (phagocyte) activity in animals fed with 1-3, 1-6 beta glucans.

Extensive work on the medical use of WGP 3-6 is being undertaken at the James Graham Brown Cancer Center, Louisville, KY, USA.

Myra L. Patchen, M.D. and others at the U.S. Armed Forces Radiobiology Institute conducted a number of studies with successful outcomes where radioactivity was involved.

Dr. Patchen, along with other scientists, suggests that beta glucan could be considered an effective way of priming the immune system and helping prevent infection.

Click here for detailed list of scientific references.